Bank of America
VOR icon

Bank of America’s Vor Biopharma VOR Stock Holding History

Bank of America’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.01M Buy
112,892
+112,496
+28,408% +$1.59M ﹤0.01% 4112
2025
Q4 		$5.18K Sell
396
-4,358
-92% -$81.1K ﹤0.01% 6270
2025
Q3 		$232K Buy
4,754
+4,723
+15,235% +$190K ﹤0.01% 6208
2025
Q2 		$989 Buy
31
+3
+11% +$27 ﹤0.01% 7532
2025
Q1 		$402 Sell
28
-92
-77% -$2.21K ﹤0.01% 7555
2024
Q4 		$2.66K Sell
120
-174
-59% -$2.88K ﹤0.01% 7169
2024
Q3 		$4.11K Sell
294
-964
-77% -$17.6K ﹤0.01% 7040
2024
Q2 		$25.2K Sell
1,258
-174
-12% -$5.63K ﹤0.01% 6682
2024
Q1 		$67.9K Sell
1,432
-1,245
-47% -$54.7K ﹤0.01% 6412
2023
Q4 		$120K Buy
2,677
+1,132
+73% +$46.7K ﹤0.01% 6299
2023
Q3 		$65.5K Buy
1,545
+608
+65% +$33K ﹤0.01% 6413
2023
Q2 		$57.9K Sell
937
-1,779
-66% -$162K ﹤0.01% 6408
2023
Q1 		$292K Buy
2,716
+2,519
+1,279% +$279K ﹤0.01% 5713
2022
Q4 		$26.2K Buy
197
+112
+132% +$11.1K ﹤0.01% 6660
2022
Q3 		$7K Buy
85
+12
+16% +$1.18K ﹤0.01% 7318
2022
Q2 		$8K Sell
73
-310
-81% -$31.7K ﹤0.01% 7474
2022
Q1 		$47K Sell
383
-320
-46% -$54.5K ﹤0.01% 7201
2021
Q4 		$163K Sell
703
-309
-31% -$89.1K ﹤0.01% 6609
2021
Q3 		$318K Buy
1,012
+65
+7% +$19.3K ﹤0.01% 5970
2021
Q2 		$353K Buy
947
+5
+0.5% +$2.47K ﹤0.01% 5684
2021
Q1 		$813K Buy
+942
New +$797K ﹤0.01% 5012

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's VOR Position: Q1 2026 in Review

Bank of America increased its Vor Biopharma (VOR) stake by 28,408% in Q1 2026, buying an estimated $1.59M and bringing the position to 112,892 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #4112.

Bank of America first reported a position in VOR in Q1 2021 and has held it in 21 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Bank of America held 112,892 shares of Vor Biopharma worth $2.01M as of Q1 2026.
  • Bank of America bought 112,496 Vor Biopharma shares in Q1 2026, an estimated $1.59M.
  • Vor Biopharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4112 holding.
  • Bank of America first reported a position in Vor Biopharma in Q1 2021 and has held it in 21 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.